Making a case for using γδ T cells against SARS-CoV-2

Mahboubeh Yazdanifar1, Narges Mashkour2, Alice Bertaina1

  • 1Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA.

Insights

Gamma delta (γδ) T lymphocytes are crucial for immune defense against respiratory viruses. This review explores their potential role in COVID-19 and strategies to enhance their antiviral function for novel therapies.

Area of Science:

  • Immunology
  • Virology
  • Cellular Biology

Background:

  • Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) infection and COVID-19 pathogenesis are under intensive investigation.
  • Gamma delta (γδ) T lymphocytes are key players in mucosal immunity and host defense against pathogens.
  • Previous research highlights the protective role of γδ T cells in SARS-CoV-1 infections.

Purpose of the Study:

  • To review the potential role of γδ T cells in the immune response to SARS-CoV-2.
  • To discuss insights from prior coronavirus research and recent findings.
  • To propose strategies for enhancing γδ T cell antiviral functions for COVID-19 therapeutic development.

Main Methods:

  • Literature review of existing research on γδ T cells and coronaviruses.
  • Analysis of the potential involvement of γδ T cells in COVID-19 pathogenesis.
  • Discussion of strategies to boost γδ T cell activity.

Main Results:

  • γδ T cells are strategically positioned at epithelial barriers, suggesting a role in early defense against respiratory viruses.
  • Existing data on γδ T cells in SARS-CoV-1 suggests potential relevance for SARS-CoV-2.
  • In vivo expansion of γδ T cells using bisphosphonates is a feasible approach for therapeutic research.

Conclusions:

  • γδ T cells represent a promising, yet understudied, component of the immune response to SARS-CoV-2.
  • Enhancing γδ T cell function could lead to novel therapeutic strategies for COVID-19.
  • Further research is warranted to elucidate the specific mechanisms and therapeutic potential of γδ T cells in COVID-19.